Stanley Laman Group Ltd. Has $3.62 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

Stanley Laman Group Ltd. grew its holdings in shares of CVS Health Co. (NYSE:CVS) by 1,366.8% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 80,672 shares of the pharmacy operator’s stock after acquiring an additional 75,172 shares during the period. Stanley Laman Group Ltd.’s holdings in CVS Health were worth $3,621,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of CVS. MidAtlantic Capital Management Inc. acquired a new position in shares of CVS Health during the third quarter valued at about $25,000. Ridgewood Investments LLC raised its position in shares of CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 450 shares during the period. Stonebridge Financial Group LLC purchased a new position in CVS Health during the fourth quarter valued at approximately $28,000. Livelsberger Financial Advisory purchased a new position in CVS Health during the third quarter valued at approximately $31,000. Finally, Legacy Investment Solutions LLC purchased a new position in CVS Health during the third quarter valued at approximately $31,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

Shares of CVS stock opened at $63.23 on Thursday. The stock’s 50-day simple moving average is $50.61 and its 200-day simple moving average is $55.92. The firm has a market capitalization of $79.57 billion, a price-to-earnings ratio of 16.05, a PEG ratio of 0.60 and a beta of 0.61. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $80.75. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. As a group, equities analysts forecast that CVS Health Co. will post 5.14 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.21%. The ex-dividend date was Thursday, January 23rd. CVS Health’s dividend payout ratio is currently 67.51%.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on CVS shares. Barclays cut their price objective on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research note on Thursday, November 7th. Wells Fargo & Company raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $60.00 to $66.00 in a research report on Monday, November 18th. Evercore ISI increased their price objective on shares of CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a research report on Monday, January 27th. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target on the stock in a report on Tuesday, December 3rd. Finally, UBS Group decreased their target price on shares of CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a research note on Tuesday. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $67.78.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.